National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

colloidal gold-bound tumor necrosis factor
A nanoparticle delivery system for recombinant human tumor necrosis factor (TNF) consisting of recombinant TNF bound to pegylated colloidal gold nanoparticles with potential antineoplastic activity. Upon intravenous administration, colloidal gold-bound recombinant human TNF travels through the bloodstream, avoiding immune detection and uptake by the reticuloendothelial system because of nanoparticle pegylation. Due to their size, the colloidal gold nanoparticles exit the circulatory system only at hyperpermeable tumor neovasculature sites; TNF then binds to and activates tumor cell TNF receptors, which may result in an increase in tumor cell apoptosis and a reduction in tumor cell proliferation. Compared to the administration of unbound TNF, colloidal gold-bound TNF may improve the efficacy and safety of TNF administration by delivering TNF specifically to tumor tissue. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:colloidal gold-bound recombinant human tumor necrosis factor
colloidal gold-bound rhTNF
colloidal gold-bound TNF
US brand name:Aurimmune
Code name:CYT-6091



Previous:codeine phosphate, coenzyme Q10, CoFactor, colchicine, collagen/aloe vera/vitamin E/lidocaine topical hydrogel
Next:Colprosterone, Combidex, combretastatin A4 analogue AVE8062, combretastatin A4 phosphate, Compound 42

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov